Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retigabine IR in Asian adults with partial-onset seizures
NCT01648101Phase 3Terminated
- Sponsor
- GSK
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of retigabine in focal onset seizure, sponsored by GSK. Started Aug 2012; status: terminated.
02
Drugs
retigabine
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT01648101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01648101.